Page last updated: 2024-09-03

imatinib mesylate and Cancer Syndromes, Hereditary

imatinib mesylate has been researched along with Cancer Syndromes, Hereditary in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
Hasegawa, M; Ieta, K; Ishida-Yamamoto, A; Ishikawa, O; Shibusawa, K; Shimizu, A; Tamura, A	1
Beets, GL; Farag, S; Steeghs, N; van Akkooi, ACJ; van Boven, HH; van der Kolk, LE; Wilmink, JW	1
Sugimura, T	1
Assie, G; Baudin, E; Bei, T; Boikos, SA; Briere, JJ; Carney, JA; Chompret, A; Ellison, JW; Eng, C; Ferrando, B; Gimenez-Roqueplo, AP; Matyakhina, L; McWhinney, SR; Muchow, M; Pacak, K; Pasini, B; Rustin, P; Stergiopoulos, S; Stratakis, CA	1

Reviews

2 review(s) available for imatinib mesylate and Cancer Syndromes, Hereditary

Article	Year
Remarkable effects of imatinib in a family with young onset gastrointestinal stromal tumors and cutaneous hyperpigmentation associated with a germline KIT-Trp557Arg mutation: case report and literature overview. Familial cancer, 2018, Volume: 17, Issue:2 Topics: Adult; Age of Onset; Antineoplastic Agents; Exons; Female; Gastrointestinal Stromal Tumors; Genetic Predisposition to Disease; Genetic Testing; Germ-Line Mutation; Humans; Hyperpigmentation; Imatinib Mesylate; Neoplastic Syndromes, Hereditary; Proto-Oncogene Proteins c-kit; Rectum; Skin; Stomach; Tomography, X-Ray Computed; Treatment Outcome; Young Adult	2018
[The principles of cancer treatment--changes in chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:7 Topics: ADP Ribose Transferases; Animals; Antineoplastic Agents; Benzamides; Cisplatin; Drug Combinations; Fluorouracil; Genes, ras; Humans; Imatinib Mesylate; Insect Proteins; Lung Neoplasms; Mice; Neoplasms; Neoplastic Syndromes, Hereditary; Oxonic Acid; Piperazines; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Signal Transduction; Tegafur; Tumor Cells, Cultured	2002

Article

Year

Remarkable effects of imatinib in a family with young onset gastrointestinal stromal tumors and cutaneous hyperpigmentation associated with a germline KIT-Trp557Arg mutation: case report and literature overview.

Familial cancer, 2018, Volume: 17, Issue:2

Topics: Adult; Age of Onset; Antineoplastic Agents; Exons; Female; Gastrointestinal Stromal Tumors; Genetic Predisposition to Disease; Genetic Testing; Germ-Line Mutation; Humans; Hyperpigmentation; Imatinib Mesylate; Neoplastic Syndromes, Hereditary; Proto-Oncogene Proteins c-kit; Rectum; Skin; Stomach; Tomography, X-Ray Computed; Treatment Outcome; Young Adult

2018

[The principles of cancer treatment--changes in chemotherapy].

Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:7

Topics: ADP Ribose Transferases; Animals; Antineoplastic Agents; Benzamides; Cisplatin; Drug Combinations; Fluorouracil; Genes, ras; Humans; Imatinib Mesylate; Insect Proteins; Lung Neoplasms; Mice; Neoplasms; Neoplastic Syndromes, Hereditary; Oxonic Acid; Piperazines; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Signal Transduction; Tegafur; Tumor Cells, Cultured

2002

Other Studies

2 other study(ies) available for imatinib mesylate and Cancer Syndromes, Hereditary

Article	Year
Generalized lentigines associated with familial gastrointestinal stromal tumors dramatically improved by imatinib treatment. The Journal of dermatology, 2020, Volume: 47, Issue:6 Topics: Chemotherapy, Adjuvant; Dermoscopy; DNA Mutational Analysis; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Female; Gastrectomy; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Gastroscopy; Humans; Imatinib Mesylate; Lentigo; Middle Aged; Neoplastic Syndromes, Hereditary; Point Mutation; Proto-Oncogene Proteins c-kit; Skin; Stomach; Treatment Outcome	2020
Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD. European journal of human genetics : EJHG, 2008, Volume: 16, Issue:1 Topics: Adolescent; Adult; Alleles; Antineoplastic Agents; Base Sequence; Benzamides; Child; DNA Primers; DNA, Neoplasm; Female; Gastrointestinal Stromal Tumors; Genes, Dominant; Germ-Line Mutation; Heterozygote; Humans; Imatinib Mesylate; Iron-Sulfur Proteins; Loss of Heterozygosity; Male; Membrane Proteins; Neoplastic Syndromes, Hereditary; Paraganglioma; Piperazines; Pyrimidines; Succinate Dehydrogenase	2008

Article

Year

Generalized lentigines associated with familial gastrointestinal stromal tumors dramatically improved by imatinib treatment.

The Journal of dermatology, 2020, Volume: 47, Issue:6

Topics: Chemotherapy, Adjuvant; Dermoscopy; DNA Mutational Analysis; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Female; Gastrectomy; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Gastroscopy; Humans; Imatinib Mesylate; Lentigo; Middle Aged; Neoplastic Syndromes, Hereditary; Point Mutation; Proto-Oncogene Proteins c-kit; Skin; Stomach; Treatment Outcome

2020

Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD.

European journal of human genetics : EJHG, 2008, Volume: 16, Issue:1

Topics: Adolescent; Adult; Alleles; Antineoplastic Agents; Base Sequence; Benzamides; Child; DNA Primers; DNA, Neoplasm; Female; Gastrointestinal Stromal Tumors; Genes, Dominant; Germ-Line Mutation; Heterozygote; Humans; Imatinib Mesylate; Iron-Sulfur Proteins; Loss of Heterozygosity; Male; Membrane Proteins; Neoplastic Syndromes, Hereditary; Paraganglioma; Piperazines; Pyrimidines; Succinate Dehydrogenase

2008